Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

Fri, 06th May 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

UBS raises Shell price target to 2,550 (2,450) pence - 'buy'

----------

Goldman Sachs raises Shell price target to 39 (37) EUR - 'buy'

----------

Jefferies raises Mondi price target to 1,775 (1,700) pence - 'buy'

----------

Morgan Stanley cuts Hikma Pharmaceuticals target to 2,100 (2,300) pence - 'equal weight'

----------

HSBC raises Flutter Entertainment price target to 14,900 (14,700) pence - 'buy'

----------

Deutsche Bank cuts Hargreaves price target to 1160 (1250) pence - 'hold'

----------

Berenberg cuts Barratt Developments price target to 790 (810) pence - 'buy'

----------

Goldman Sachs cuts Next price target to 8,200 (8,500) pence - 'buy'

----------

RBC raises HSBC price target to 590 (550) pence - 'outperform'

----------

FTSE 250

----------

Liberum raises Trainline price target to 435 (400) pence - 'buy'

----------

Morgan Stanley raises Trainline price target to 310 (270) p - 'equal-weight'

----------

Barclays raises Trainline price target to 280 (200) pence - 'underweight'

----------

Morgan Stanley cuts Travis Perkins target to 1,870 (2,000) pence - 'overweight'

----------

HSBC cuts Centrica to 'reduce' (hold)

----------

Citigroup cuts Direct Line price target to 286 (317) pence - 'buy'

----------

JPMorgan raises Beazley price target to 670 (650) pence - 'overweight'

----------

Barclays raises Virgin Money price target to 245 (225) pence - 'equal weight'

----------

RBC raises Greencoat UK Wind price target to 200 (170) pence - 'outperform'

----------

UBS raises Man Group price target to 305 (285) pence - 'buy'

----------

UBS cuts Jupiter Fund price target to 180 (210) pence - 'neutral'

----------

Jefferies cuts Rathbones to 'hold' (buy) - price target 2,100 (1,900) pence

----------

Jefferies raises Qinetiq price target to 405 (350) pence - 'buy'

----------

Jefferies raises Chemring Group price target to 350 (300) pence - 'hold'

----------

JPMorgan raises Hiscox price target to 895 (870) pence - 'underweight'

----------

Morgan Stanley raises Hiscox price target to 1,194 (1,159) pence - 'overweight'

----------

SMALL CAP

----------

Barclays cuts Reach price target to 135 (185) pence - 'equal weight'

----------

RBC raises Greencoat Renewables price target to 1.50 (1.30) pence - outperform

----------

Goldman Sachs starts Petrofac with 'buy' - price target 170 pence

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.